Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kuniaki Moriki"'
Autor:
Masako Ishida, Takeshi Kumagai, Tatsuro Yamamoto, Hiroyuki Suzuki, Kuniaki Moriki, Masachika Fujiyoshi, Kiyoshi Nagata, Miki Shimada
Publikováno v:
Yonago Acta Medica; 2024, Vol. 67 Issue 1, p1-40, 10p
Autor:
Hiroshi Takane, Tatsuya Kaneda, Kuniaki Moriki, Miki Shimada, Yoshikazu Shiinoki, Kazumasa Shinozuka, Katsuhiro Ogawa, Makiko Adachi
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 42:217-227
Autor:
Ichiro Ieiri, Saki Shigematsu, Hiroshi Takane, Daiki Yamashita, Kuniaki Moriki, Masaaki Hirakawa, Takeshi Hirota, Shota Muraki, Masato Fukae, Makoto Kakara, Miki Shimada
Publikováno v:
Journal of clinical pharmacology. 58(3)
The aim of this study was to develop a population pharmacodynamic (PPD) model to describe uric acid (UA)-lowering effects in patients treated with febuxostat based on electronic medical records in 2 independent hospitals (university and city hospital
Autor:
Kuniaki Moriki, Isao Adachi, Yasuyoshi Kawata, Megumi Yasui, Atsushi Kato, Jackie Hollinshead, Natsuki Yano, Robert J. Nash
Publikováno v:
Phytochemistry Letters. 2:77-80
Chromatographic separation of an extract of the stems of Sinomenium acutum resulted in the isolation of two new alkaloids, 2-O-demethyl-acutumine (4), and 6-O-methyl-laudanosoline-1-O-glucoside (5), together with three known alkaloids, sinomenine (1)
Autor:
Ichiro Ieiri, Hiroya Kitano, Hiroshi Takane, Kenji Otsubo, Tomohiro Sasaki, Katsuyuki Kawamoto, Kazuyo Moriki, Kuniaki Moriki, Shun Higuchi
Publikováno v:
Cancer chemotherapy and pharmacology. 63(6)
To explore severe toxicities induced by irinotecan-based chemotherapy and UGT1A1*6/*28 and SLCO1B1*15/*15 genotypes.A 66-year-old Japanese male diagnosed with left pharyngeal carcinoma (T2N2bM0, stage IVA) was treated with irinotecan (70 mg/m(2)) on